Alirocumab Market Poised for Significant Growth Amidst Rising Cardiovascular Health Awareness and Biotech Innovation
Read More=> https://dataintelo.com/report/....global-alirocumab-ma
The global Alirocumab Market is experiencing strong growth, fueled by rising incidences of cardiovascular diseases and growing demand for advanced lipid-lowering therapies. Alirocumab, a PCSK9 inhibitor, is increasingly adopted as a treatment for hypercholesterolemia and atherosclerotic cardiovascular conditions, especially in patients who are unresponsive to conventional statins.